BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Ebola Hemorrhagic Fevers

Below is an extended Ebola Hemorrhagic Fevers research listing. Click here to return to the Ebola Hemorrhagic Fevers main in depth entry.

Recent Publications on Ebola Hemorrhagic Fevers:

Viral haemorrhagic fever and vascular alterations. 30th August, 2008
Institut fur Physiologie, Technische Universitat, Medizinische Fakultat,
[The strategic plan for preparedness and response to bioterrorism in Korea.]
Following the Anthrax bioterrorism attacks in the US in 2001, the Korean...
Direct Link
31st July, 2008
Korea Centers for Disease Control and Prevention, Ministry for Health,
Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. 30th July, 2008
US Army Medical Research Institute of Infectious Diseases, Fort Detrick,
The 1995 Kikwit Ebola outbreak--model of virus properties on system capacity and function: a lesson for future viral epidemics. 30th July, 2008
Case Western Reserve, Cleveland, Ohio, USA.
Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
The filoviruses, Marburg and Ebola, have the dubious distinction of being...
Direct Link
19th June, 2008
Tulane University Health Sciences Center, New Orleans, LA, United States.
Protection against filovirus infection: virus-like particle vaccines.
Significant progress has been made in vaccine development against...
Direct Link
12th June, 2008
Department of Microbiology and Immunology and Emory Vaccine Center, Emory
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
Recombinant vesicular stomatitis virus (VSV) vectors expressing homologous...
Direct Link
12th June, 2008
National Emerging Infectious Diseases Laboratories Institute, Boston,
Functional CD8+ T cell responses in lethal Ebola virus infection. 11th June, 2008
United States Army Medical Research Institute of Infectious Diseases, Fort
The strains of Ebola.
The 1995 Kikwit Ebola outbreak in the Democratic Republic of the Congo is...
Direct Link
5th June, 2008
ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response.
Interferons regulate diverse immune functions through the transcriptional...
Direct Link
23rd May, 2008
Department of Molecular and Experimental Medicine, The Scripps Research
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
Filoviruses (Ebola and Marburg viruses) are among the deadliest viruses...
Direct Link
17th April, 2008
U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter
Filovirus research: knowledge expands to meet a growing threat.
Filoviruses (Ebola and Marburg viruses) are among the deadliest viruses...
Direct Link
25th January, 2008
Integrated Research Facility, National Institute of Allergy and Infectious
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
BACKGROUND: Currently, there are no licensed vaccines or therapeutics for...
Direct Link
25th January, 2008
US Army Medical Research Institute of Infectious Diseases, Fort Detrick,
Ebola outbreak in Uganda "atypical", say experts. 8th January, 2008
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional